Therma Bright Inc. (TSXV:THRM)
0.0350
0.00 (0.00%)
Nov 20, 2026, 4:00 PM EST
Therma Bright Revenue
Therma Bright had revenue of 70.19K CAD in the quarter ending April 30, 2026, with 3,771.37% growth. This brings the company's total for the last twelve months to 135.82K, up 343.52% year-over-year. In the fiscal year ending July 31, 2025, Therma Bright had annual revenue of 75.23K with 1,150.67% growth. That makes Therma Bright the 46,150th largest company in the world by revenue and 1,059th in Canada.
Revenue (ttm)
135.82K
Revenue Growth
+343.52%
P/S Ratio
17.49
Revenue / Employee
n/a
Employees
n/a
Market Cap
2.38M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jul 31, 2025 | 75.23K | 69.21K | 1,150.67% |
| Jul 31, 2024 | 6.02K | 3.96K | 192.56% |
| Jul 31, 2023 | 2.06K | -137.37K | -98.53% |
| Jul 31, 2022 | 139.43K | 135.54K | 3,490.70% |
| Jul 31, 2021 | 3.88K | 100.00 | 2.64% |
| Jul 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jul 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Aurora Spine | 24.92M |
| Conavi Medical | 845.00K |
| Frequency Exchange | 647.43K |
| MedX Health | 569.79K |
| NuGen Medical Devices | 148.72K |
| Ventripoint Diagnostics | 147.77K |
| VVT Med | 136.33K |
| Aquarius Surgical Technologies | 91.62K |
Therma Bright News
- 8 days ago - Therma Bright Increases Non-Brokered Private Placement up to $500,000 - Newsfile Corp
- 4 weeks ago - Therma Bright Announces up to $420,000 Non-Brokered Private Placement - Newsfile Corp
- 3 months ago - Therma Bright Inc. Completes Debt Settlements - Newsfile Corp
- 5 months ago - Therma Bright Announces Expanded U.S. Orders for Venowave and Mobilizes Supply Chain for Upcoming Sales Volume - Newsfile Corp
- 6 months ago - Therma Bright Announces Follow-On Order from Horizon Health as Venowave(TM) Gains Traction in U.S. Vascular Markets - Newsfile Corp
- 7 months ago - Therma Bright Signs New Strategic Customer, Horizon Health, Currently Selling over 35,000 Compression Products Annually - Newsfile Corp
- 8 months ago - Therma Bright Grants Stock Options - Newsfile Corp
- 9 months ago - Therma Bright Portfolio Update: Inretio Successfully Completes First-in-Human Cohort for PREVA(TM) Stroke Platform; Targets 2026 U.S. FDA Trial - Newsfile Corp